New expectations in the treatment of anemia in chronic kidney disease

详细信息    查看全文

• 作者：Juan M. Ló ; pez-Gó ; mez ; ^{juanmlopez@senefro.org" class="auth_mail" title="E-mail the corresponding author} ; Soraya Abad ; Almudena Vega
• 关键词：Chronic kidney disease ; Anemia ; Prolyl-hydroxylase inhibitors ; Sotatercept ; Hepcidin
• 刊名：Nefrología (English Edition)
• 出版年：2016
• 出版时间：May-June 2016
• 年：2016
• 卷：36
• 期：3
• 页码：232-236
• 全文大小：494 K

文摘

The new drugs developed for the treatment of anemia in chronic kidney disease patients, together with their mechanisms of action are reviewed. At present, many of them are already in advanced stages of clinical trials and is expected to be incorporated into the therapeutic arsenal in the coming years. The potential benefits and possible limitations are also described.